advertisement

Rangers bring 2-1 series lead into game 4 against the Lightning

New York Rangers (52-24-6, second in the Metropolitan Division) vs. Tampa Bay Lightning (51-23-8, third in the Atlantic Division)

Tampa, Florida; Tuesday, 8 p.m. EDT

FANDUEL SPORTSBOOK LINE: Lightning -172, Rangers +147; over/under is 5.5

STANLEY CUP SEMIFINALS: Rangers lead series 2-1

BOTTOM LINE: The New York Rangers visit the Tampa Bay Lightning in the third round of the NHL Playoffs with a 2-1 lead in the series. The teams meet Sunday for the sixth time this season. The Lightning won 3-2 in the previous meeting.

Tampa Bay has a 51-23-8 record overall and a 24-8-6 record on its home ice. The Lightning have gone 19-8-3 when they commit fewer penalties than their opponent.

New York has a 24-13-2 record on the road and a 52-24-6 record overall. The Rangers have a 19-6-2 record when they commit fewer penalties than their opponent.

TOP PERFORMERS: Victor Hedman has 20 goals and 66 assists for the Lightning. Nikita Kucherov has five goals and 10 assists over the last 10 games.

Artemi Panarin has scored 22 goals with 74 assists for the Rangers. Mika Zibanejad has seven goals and six assists over the last 10 games.

LAST 10 GAMES: Lightning: 7-3-0, averaging 2.9 goals, 4.8 assists, 4.1 penalties and 8.4 penalty minutes while giving up 2.2 goals per game.

Rangers: 6-3-1, averaging 3.1 goals, 5.3 assists, 4.1 penalties and 8.5 penalty minutes while giving up 1.9 goals per game.

INJURIES: Lightning: Brayden Point: out (leg).

Rangers: Barclay Goodrow: out (lower body), Sammy Blais: out for season (lower body).

___

The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.

Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.